Dr Reddys Laboratories Stock Price on October 7, 2024
| RDY Stock | USD 14.14 0.06 0.43% |
Below is the normalized historical share price chart for Dr Reddys Laboratories extending back to April 11, 2001. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Dr Reddys stands at 14.14, as last reported on the 30th of November, with the highest price reaching 14.21 and the lowest price hitting 14.10 during the day.
If you're considering investing in RDY Stock, it is important to understand the factors that can impact its price. Dr Reddys Laboratories retains Efficiency (Sharpe Ratio) of -0.16, which denotes the company had a -0.16% return per unit of price deviation over the last 3 months. Dr Reddys exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Dr Reddys' Information Ratio of (0.29), market risk adjusted performance of (0.26), and Standard Deviation of 1.31 to check the risk estimate we provide.
At this time, Dr Reddys' Total Stockholder Equity is fairly stable compared to the past year. Common Stock is likely to rise to about 1.1 B in 2024, whereas Liabilities And Stockholders Equity is likely to drop slightly above 223.8 B in 2024. . At this time, Dr Reddys' Price To Sales Ratio is fairly stable compared to the past year. Price Book Value Ratio is likely to rise to 3.89 in 2024, whereas Price Earnings Ratio is likely to drop 10.24 in 2024. RDY Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 11th of April 2001 | 200 Day MA 15.1741 | 50 Day MA 15.239 | Beta 0.328 |
RDY |
Sharpe Ratio = -0.1641
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | RDY |
Estimated Market Risk
| 1.28 actual daily | 11 89% of assets are more volatile |
Expected Return
| -0.21 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.16 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Dr Reddys is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Dr Reddys by adding Dr Reddys to a well-diversified portfolio.
Price Book 3.2398 | Enterprise Value Ebitda 10.9661 | Price Sales 0.0395 | Shares Float 599.5 M | Dividend Share 8 |
Related Headline
Amicus Therapeutics Headline on 7th of October 2024
Bradley L. Campbell Sells 7,500 Shares of Amicus Therapeutic... by thelincolnianonline.com
Amicus Therapeutics, Inc. CEO Bradley L. Campbell sold 7,500 shares of the companys stock in a transaction that occurred on Tuesday, October 1st. The stock was sold at an average price of 10.60, for a total value of 79,500.00. Following the transaction, the chief executive officer now directly owns 886,654
Dr Reddys Valuation on October 7, 2024
It is possible to determine the worth of Dr Reddys on a given historical date. On October 7, 2024 RDY was worth 15.61 at the beginning of the trading date compared to the closed value of 15.53. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Dr Reddys stock. Still, in general, we apply an absolute valuation method to find Dr Reddys' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Dr Reddys where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Dr Reddys' related companies.
| Open | High | Low | Close | Volume | |
| 15.80 | 15.87 | 15.64 | 15.65 | 675,085 | |
10/07/2024 | 15.61 | 15.68 | 15.44 | 15.53 | 552,270 |
| 15.74 | 15.79 | 15.68 | 15.75 | 814,235 |
| Backtest Dr Reddys | | | Dr Reddys History | | | Dr Reddys Valuation | Previous | Next |
Dr Reddys Trading Date Momentum on October 7, 2024
| On October 08 2024 Dr Reddys Laboratories was traded for 15.75 at the closing time. Highest Dr Reddys's price during the trading hours was 15.79 and the lowest price during the day was 15.68 . The net volume was 814.2 K. The overall trading history on the 8th of October contributed to the next trading period price jump. The trading delta at closing time to the next next day price was 1.42% . The overall trading delta to current price is 2.06% . |
Dr Reddys Laboratories Fundamentals Correlations and Trends
By evaluating Dr Reddys' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Dr Reddys' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. RDY financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Dr Reddys Stock history
Dr Reddys investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for RDY is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Dr Reddys Laboratories will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Dr Reddys stock prices may prove useful in developing a viable investing in Dr Reddys
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 166.7 M | 175.5 M | |
| Net Income Applicable To Common Shares | 51.8 B | 54.4 B |
Dr Reddys Quarterly Net Working Capital |
|
Dr Reddys Stock Technical Analysis
Dr Reddys technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Dr Reddys Period Price Range
Low | November 30, 2024
| High |
0.00 | 0.00 |
Dr Reddys Laboratories cannot be verified against its exchange. Please verify the symbol is currently traded on New York Stock Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Dr Reddys November 30, 2024 Market Strength
Market strength indicators help investors to evaluate how Dr Reddys stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Dr Reddys shares will generate the highest return on investment. By undertsting and applying Dr Reddys stock market strength indicators, traders can identify Dr Reddys Laboratories entry and exit signals to maximize returns
Dr Reddys Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Dr Reddys' price direction in advance. Along with the technical and fundamental analysis of RDY Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of RDY to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.13) | |||
| Jensen Alpha | (0.36) | |||
| Total Risk Alpha | (0.47) | |||
| Treynor Ratio | (0.27) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for RDY Stock Analysis
When running Dr Reddys' price analysis, check to measure Dr Reddys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Reddys is operating at the current time. Most of Dr Reddys' value examination focuses on studying past and present price action to predict the probability of Dr Reddys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dr Reddys' price. Additionally, you may evaluate how the addition of Dr Reddys to your portfolios can decrease your overall portfolio volatility.